p53 Family in Resistance to Targeted Therapy of Melanoma
Ignacija Vlašić(Ruđer Bošković Institute), Neda Slade(Ruđer Bošković Institute), Ana Tadijan(Ruđer Bošković Institute), Anđela Horvat(Ruđer Bošković Institute)
Cited by 34
Related Papers
Fractionation and turnover of stable carbon isotopes in animal tissues: Implications for ?13C analysis of diet
|Oecologia|1983|1.8k
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
|Proceedings of the National Academy of Sciences|2007|598
p63 and p73: Roles in Development and Tumor Formation
|Molecular Cancer Research|2004|492
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
|The Journal of Experimental Medicine|2002|317
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
|Kidney International|2011|213